Long-term outcomes from the phase II L-MIND study of tafasitamab (MOR208) plus lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma
Duell, Johannes, Maddocks, Kami J., González-Barca, Eva, Jurczak, Wojciech, Liberati, Anna Marina, De Vos, Sven, Nagy, Zsolt, Obr, Aleš, Gaidano, Gianluca, Abrisqueta, Pau, Kalakonda, Nagesh, André, Marc, Dreyling, Martin, Menne, Tobias, Tournilhac, Olivier, Augustin, Marinela, Rosenwald, Andreas, Dirnberger-Hertweck, Maren, Weirather, Johannes, Ambarkhane, Sumeet, Salles, Gilles
Published in Haematologica (Roma) (01.09.2021)
Published in Haematologica (Roma) (01.09.2021)
Get full text
Journal Article
Long-term outcomes from the phase II L-MIND study of tafasitamab (MOR208) plus lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma
Duell, Johannes, Maddocks, Kami J., González-Barca, Eva, Jurczak, Wojciech, Liberati, Anna Marina, De Vos, Sven, Nagy, Zsolt, Obr, Aleš, Gaidano, Gianluca, Abrisqueta, Pau, Kalakonda, Nagesh, André, Marc, Dreyling, Martin, Menne, Tobias, Tournilhac, Olivier, Augustin, Marinela, Rosenwald, Andreas, Dirnberger-Hertweck, Maren, Weirather, Johannes, Ambarkhane, Sumeet, Salles, Gilles
Published in Haematologica (Roma) (19.08.2021)
Published in Haematologica (Roma) (19.08.2021)
Get full text
Journal Article
Tafasitamab plus lenalidomide in relapsed or refractory diffuse large B-cell lymphoma (L-MIND): a multicentre, prospective, single-arm, phase 2 study
Salles, Gilles, Duell, Johannes, González Barca, Eva, Tournilhac, Olivier, Jurczak, Wojciech, Liberati, Anna Marina, Nagy, Zsolt, Obr, Aleš, Gaidano, Gianluca, André, Marc, Kalakonda, Nagesh, Dreyling, Martin, Weirather, Johannes, Dirnberger-Hertweck, Maren, Ambarkhane, Sumeet, Fingerle-Rowson, Günter, Maddocks, Kami
Published in The lancet oncology (01.07.2020)
Published in The lancet oncology (01.07.2020)
Get full text
Journal Article
CD19 expression is maintained in DLBCL patients after treatment with tafasitamab plus lenalidomide in the L-MIND study
Duell, Johannes, Obr, Aleš, Augustin, Marinela, Endell, Jan, Liu, Hao, Geiger, Sabine, Silverman, Ian M., Ambarkhane, Sumeet, Rosenwald, Andreas
Published in Leukemia & lymphoma (28.01.2022)
Published in Leukemia & lymphoma (28.01.2022)
Get full text
Journal Article
Several factors that predict the outcome of large B‐cell lymphoma patients who relapse/progress after chimeric antigen receptor (CAR) T‐cell therapy can be identified before cell administration
Sýkorová, Alice, Folber, František, Polgárová, Kamila, Móciková, Heidi, Ďuraš, Juraj, Steinerová, Kateřina, Obr, Aleš, Heindorfer, Adriana, Ladická, Miriam, Lukáčová, Ľubica, Čellárová, Erika, Plameňová, Ivana, Belada, David, Janíková, Andrea, Trněný, Marek, Jančárková, Tereza, Procházka, Vít, Vranovský, Andrej, Králiková, Margaréta, Vydra, Jan, Smolej, Lukáš, Drgoňa, Ľuboš, Sedmina, Martin, Čermáková, Eva, Pytlík, Robert
Published in Cancer medicine (Malden, MA) (01.09.2024)
Published in Cancer medicine (Malden, MA) (01.09.2024)
Get full text
Journal Article
TP53 Mutation and Complex Karyotype Portends a Dismal Prognosis in Patients With Mantle Cell Lymphoma
Obr, Aleš, Procházka, Vít, Jirkuvová, Andrea, Urbánková, Helena, Kriegova, Eva, Schneiderová, Petra, Vatolíková, Michaela, Papajík, Tomáš
Published in Clinical lymphoma, myeloma and leukemia (01.11.2018)
Published in Clinical lymphoma, myeloma and leukemia (01.11.2018)
Get full text
Journal Article
Maintenance rituximab in newly diagnosed mantle cell lymphoma patients: a real world analysis from the Czech lymphoma study group registry
Obr, Aleš, Prochazka, Vit, Papajik, Tomas, Klener, Pavel, Janikova, Andrea, Salek, David, Belada, David, Pytlík, Robert, Sykorova, Alice, Mocikova, Heidi, Simkovic, Martin, Campr, Vit, Dlouha, Jitka, Furst, Tomas, Trněný, Marek
Published in Leukemia & lymphoma (23.02.2019)
Published in Leukemia & lymphoma (23.02.2019)
Get full text
Journal Article
COVID-19 in 96 Patients With Hematologic Disease: The First Single-center Experience From the Czech Republic
Čerňan, Martin, Szotkowski, Tomáš, Obr, Aleš, Látal, Vojtěch, Hluší, Antonín, Krhovská, Petra, Klementová, Olga, Kolář, Milan, Sauer, Pavel, Faber, Edgar, Fürst, Tomáš, Papajík, Tomáš
Published in Clinical lymphoma, myeloma and leukemia (01.09.2021)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2021)
Get full text
Journal Article
Ibrutinib in Mantle Cell Lymphoma Patients: Analysis of the Czech Lymphoma Study Group
Obr, Aleš, Klener, Pavel, Janíková, Andrea, Mocikova, Heidi, Belada, David, Šálek, David, Sýkorová, Alice, Jirkuvová, Andrea, Papajík, Tomáš, Trněný, Marek
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article
Long-term analyses from L-MIND, a phase II study of tafasitamab (MOR208) combined with lenalidomide (LEN) in patients with relapsed or refractory diffuse large B-cell lymphoma (R/R DLBCL)
Düll, Johannes, Maddocks, Kami J., Gonzalez-Barca, Eva, Jurczak, Wojciech, Liberati, Anna Marina, Obr, Aleš, Gaidano, Gianluca, Abrisqueta, Pau, André, Marc, Dreyling, Martin H., Menne, Tobias, Dirnberger-Hertweck, Maren, Weirather, Johannes, Ambarkhane, Sumeet Vijay, Salles, Gilles A.
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
High TP53 Mutation Load Predicts Primary Refractory Mantle Cell Lymphoma
Obr, Aleš, Klener, Pavel, Kriegova, Eva, Zemanova, Zuzana, Urbankova, Helena, Jirkuvova, Andrea, Petrackova, Anna, Cudova, Barbora, Sedlarikova, Lenka, Prochazka, VIT K, Papajik, Tomas, Trneny, Marek
Published in Blood (13.11.2019)
Published in Blood (13.11.2019)
Get full text
Journal Article
Long-Term Subgroup Analyses from L-Mind, a Phase II Study of Tafasitamab (MOR208) Combined with Lenalidomide in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Maddocks, Kami J., Duell, Johannes, González-Barca, Eva, Jurczak, Wojciech, Liberati, Anna Marina, de Vos, Sven, Nagy, Zsolt, Obr, Aleš, Gaidano, Gianluca, Abrisqueta, Pau, André, Marc, Dreyling, Martin, Menne, Tobias F, Dirnberger-Hertweck, Maren, Weirather, Johannes, Ambarkhane, Sumeet, Salles, Gilles
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article
Subgroup Analyses from L-Mind, a Phase II Study of Tafasitamab (MOR208) Combined with Lenalidomide in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Duell, Johannes, Maddocks, Kami J., González-Barca, Eva, Jurczak, Wojciech, Liberati, Anna Marina, de Vos, Sven, Nagy, Zsolt, Obr, Aleš, Gaidano, Gianluca, Abrisqueta, Pau, André, Marc, Dreyling, Martin, Menne, Tobias F, Dirnberger-Hertweck, Maren, Weirather, Johannes, Ambarkhane, Sumeet, Salles, Gilles A.
Published in Blood (13.11.2019)
Published in Blood (13.11.2019)
Get full text
Journal Article
Update of the single-arm phase II L-MIND study of MOR208 + lenalidomide (LEN) in relapsed/refractory diffuse large B-cell lymphoma (R-R DLBCL): Response rates in patient subgroups with poor prognosis
Maddocks, Kami J., Duell, Johannes, González Barca, Eva, Jurczak, Wojciech, Liberati, Anna Marina, Nagy, Zsolt, Obr, Aleš, Gaidano, Gianluca, André, Marc, Kalakonda, Nagesh, Dreyling, Martin H., Zinzani, Pier Luigi, Dirnberger-Hertweck, Maren, Weirather, Johannes, Ambarkhane, Sumeet Vijay, Salles, Gilles A.
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
Long-term outcomes from the phase II L-MIND study of tafasitamab (MOR208) plus lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma
Duell, Johannes, Maddocks, Kami J., González-Barca, Eva, Jurczak, Wojciech, Liberati, Anna Marina, de Vos, Sven, Nagy, Zsolt, Obr, Aleš, Gaidano, Gianluca, Abrisqueta, Pau, Kalakonda, Nagesh, André, Marc, Dreyling, Martin, Menne, Tobias, Tournilhac, Olivier, Augustin, Marinela, Rosenwald, Andreas, Dirnberger-Hertweck, Maren, Weirather, Johannes, Ambarkhane, Sumeet, Salles, Gilles
Published in Haematologica (Roma) (01.07.2021)
Published in Haematologica (Roma) (01.07.2021)
Get full text
Journal Article
Single-Arm Phase II Study of MOR208 Combined with Lenalidomide in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma: L-Mind
Salles, Gilles Andre, Duell, Johannes, González-Barca, Eva, Jurczak, Wojciech, Liberati, Anna Marina, Nagy, Zsolt, Obr, Aleš, Gaidano, Gianluca, Andre, Marc, Kalakonda, Nagesh, Dreyling, Martin, Zinzani, Pier Luigi, Dirnberger-Hertweck, Maren, Weirather, Johannes, Ambarkhane, Sumeet, Maddocks, Kami J.
Published in Blood (29.11.2018)
Published in Blood (29.11.2018)
Get full text
Journal Article
Rituximab Maintenance Failure in Mantle Cell Lymphoma Is Associated with High Risk of Death: Analysis of the Czech Lymphoma Study Group (CLSG)
Obr, Aleš, Prochazka, Vit, Papajik, Tomas, Klener, Pavel, Janikova, Andrea, Salek, David, Belada, David, Pytlik, Robert, Sýkorová, Alice, Mocikova, Heidi, Simkovic, Martin, Campr, Vit, Dlouha, Jitka, Fuerst, Tomas, Trněný, Marek
Published in Blood (08.12.2017)
Published in Blood (08.12.2017)
Get full text
Journal Article
LYMRIT 37-01: A Phase I/II Study of 177lu-Lilotomab Satetraxetan (Betalutin®) Antibody-Radionuclide-Conjugate (ARC) for the Treatment of Relapsed Non-Hodgkin's Lymphoma (NHL) — Analysis with 6-Month Follow-up
Kolstad, Arne, Madsbu, Ulf, Beasley, Matthew, Bayne, Michael, Illidge, Tim M., O'Rourke, Noelle, Lagerlöf, Ingemar, Hajek, Roman, Jurczak, Wojciech, Willenbacher, Ella, Fagerli, Unn Merete, Obr, Aleš, Blakkisrud, Johan, Muftuler Løndalen, Ayca, Rojkjaer, Lisa, Østengen, Åse, Bolstad, Nils, Spetalen, Signe, Erlanson, Martin, Galleberg, Renate, Nygaard Rudå, Stine, Holte, Harald
Published in Blood (29.11.2018)
Published in Blood (29.11.2018)
Get full text
Journal Article
ABCL-170: Long-Term Outcomes from the Phase II L-MIND Study of Tafasitamab (MOR208) Plus Lenalidomide in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Salles, Gilles, Duell, Johannes, González-Barca, Eva, Jurczak, Wojciech, Marina Liberati, Anna, de Vos, Sven, Nagy, Zsolt, Obr, Aleš, Gaidano, Gianluca, Abrisqueta, Pau, Kalakonda, Nagesh, André, Marc, Dreyling, Martin, Menne, Tobias, Tournilhac, Olivier, Augustin, Marinela, Dirnberger-Hertweck, Maren, Weirather, Johannes, Ambarkhane, Sumeet, Maddocks, Kami J
Published in Clinical lymphoma, myeloma and leukemia (01.09.2020)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2020)
Get full text
Journal Article
Phase 1/2a study of 177Lu-lilotomab satetraxetan in relapsed/refractory indolent non-Hodgkin lymphoma
Kolstad, Arne, Illidge, Tim, Bolstad, Nils, Spetalen, Signe, Madsbu, Ulf, Stokke, Caroline, Blakkisrud, Johan, Løndalen, Ayca, O'Rourke, Noelle, Beasley, Matthew, Jurczak, Wojciech, Fagerli, Unn-Merete, Kaščák, Michal, Bayne, Mike, Obr, Aleš, Dahle, Jostein, Rojkjaer, Lisa, Pascal, Veronique, Holte, Harald
Published in Blood advances (08.09.2020)
Published in Blood advances (08.09.2020)
Get full text
Journal Article